Thioredoxin-1 protects against neutrophilic inflammation and emphysema progression in a mouse model of chronic obstructive pulmonary disease exacerbation.
BACKGROUND: Exacerbations of chronic obstructive pulmonary disease (COPD) are characterized by acute enhancement of airway neutrophilic inflammation under oxidative stress and can be involved in emphysema progression. However, pharmacotherapy against the neutrophilic inflammation and emphysema progr...
Main Authors: | Naoya Tanabe, Yuma Hoshino, Satoshi Marumo, Hirofumi Kiyokawa, Susumu Sato, Daisuke Kinose, Kazuko Uno, Shigeo Muro, Toyohiro Hirai, Junji Yodoi, Michiaki Mishima |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3823967?pdf=render |
Similar Items
-
Longitudinal study of spatially heterogeneous emphysema progression in current smokers with chronic obstructive pulmonary disease.
by: Naoya Tanabe, et al.
Published: (2012-01-01) -
Correction: Longitudinal Study of Spatially Heterogeneous Emphysema Progression in Current Smokers with Chronic Obstructive Pulmonary Disease
by: Naoya Tanabe, et al.
Published: (2012-01-01) -
Correction: Longitudinal Study of Spatially Heterogeneous Emphysema Progression in Current Smokers with Chronic Obstructive Pulmonary Disease.
by: Naoya Tanabe, et al.
Published: (2012-01-01) -
Emphysema distribution and annual changes in pulmonary function in male patients with chronic obstructive pulmonary disease
by: Tanabe Naoya, et al.
Published: (2012-04-01) -
Relationship between periodontitis-related antibody and frequent exacerbations in chronic obstructive pulmonary disease.
by: Tamaki Takahashi, et al.
Published: (2012-01-01)